BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2025 1:39:41 PM | Browse: 2 | Download: 0
 |
Received |
|
2025-04-02 02:39 |
|
Peer-Review Started |
|
2025-04-02 02:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-09 11:58 |
|
Revised |
|
2025-04-17 05:39 |
|
Second Decision |
|
2025-05-13 02:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-05-13 06:58 |
|
Articles in Press |
|
2025-05-13 06:58 |
|
Publication Fee Transferred |
|
2025-04-19 04:15 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-21 09:49 |
|
Publish the Manuscript Online |
|
2025-06-13 13:39 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhi-Yuan Yao, Jie Liu, Xiao Ma, Wan-Ting Li, Yu Shen, Yong-Zheng Cui, Yan Fang, Zheng-Xiang Han and Chun-Hua Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chun-Hua Yang, MD, PhD, Professor, Department of Radiotherapy, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. 13063518075@126.com |
| Key Words |
Gastric cancer; HER2-negative gastric cancer; Programmed death-1 inhibitor; Predictive model; Efficacy; Safety |
| Core Tip |
This study is the first to validate the prognostic value of the fibrinogen-to-albumin ratio (FAR) in advanced HER2-negative gastric cancer patients receiving immunochemotherapy. High FAR was significantly associated with shorter progression-free survival and overall survival, establishing FAR as an independent prognostic factor. The predictive model incorporating FAR allows for personalized survival predictions, offering a valuable and cost-effective tool for clinical decision-making. These findings underscore FAR's potential as a practical biomarker for guiding treatment strategies in advanced gastric cancer. |
| Publish Date |
2025-06-13 13:39 |
| Citation |
<p>Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. <i>World J Gastrointest Oncol</i> 2025; 17(6): 107980</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i6.107980 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
